Cancer stem cells

GPTKB entity

Statements (65)
Predicate Object
gptkbp:instanceOf Stem cells
gptkbp:associated_with Tumor heterogeneity
Epithelial-mesenchymal transition
Increased metastasis risk
Invasive cancer
Tumor aggressiveness
gptkbp:contributedTo Metastasis
gptkbp:culturalHeritage Laboratory conditions
gptkbp:divisions Bone marrow
Tumor biopsies
gptkbp:exhibits Self-renewal
gptkbp:has_a_focus_on Regenerative medicine
Personalized medicine
gptkbp:hasRole Tumor initiation
https://www.w3.org/2000/01/rdf-schema#label Cancer stem cells
gptkbp:influence Tumor microenvironment
Immune evasion
gptkbp:influenced Hypoxia
Cytokines
Epigenetic changes
Microenvironmental factors
Niche factors
gptkbp:is_a_key_component_of Tumor-initiating cells
gptkbp:is_a_subject_of Clinical trials
gptkbp:is_accessible_by Magnetic-activated cell sorting
gptkbp:is_aimed_at Gene therapy
Immunotherapy
Small molecule inhibitors
Novel therapies
gptkbp:is_available_in Solid tumors
Hematological malignancies
gptkbp:is_characterized_by Metabolic pathways
Altered signaling pathways
Cell surface proteins
Gene expression profiles
High tumorigenicity
Resistance to apoptosis
gptkbp:is_involved_in Cell cycle regulation
Angiogenesis
Cell signaling pathways
Drug resistance
Tumor progression
Chemotherapy resistance
Tumor evolution
Cellular plasticity
Cancer recurrence
Therapeutic failure
Tumor immune escape
gptkbp:is_linked_to Poor prognosis
gptkbp:is_recognized_for Flow cytometry
Specific markers
gptkbp:is_studied_in Cancer research
Stem cell biology
Tumor microenvironment interactions
Biomarker_discovery
Therapeutic_targets
Therapeutic_resistance_mechanisms
gptkbp:isNotableFor Conventional therapies
gptkbp:isUsedFor Induced pluripotent stem cells
Cancerous tissues
gptkbp:originatesFrom Normal stem cells
gptkbp:provides Specific surface markers
gptkbp:recognizes Biomarkers
gptkbp:variant Various cell types
gptkbp:worksWith Targeted therapies